|  Help  |  About  |  Contact Us

Publication : Fibrillar Abeta causes profound microglial metabolic perturbations in a novel APP knock-in mouse model.

First Author  Xia D Year  2021
Journal  bioRxiv Mgi Jnum  J:299724
Mgi Id  MGI:6501573 Doi  10.1101/2021.01.19.426731
Citation  Xia D, et al. (2021) Fibrillar Abeta causes profound microglial metabolic perturbations in a novel APP knock-in mouse model. bioRxiv
abstractText  Microglial dysfunction is believed to play a pathogenic role in Alzheimer’s disease (AD). Here, we characterize the amyloid-b related pathology and microglial responses in an engineered APP knock-in mouse model of familial AD. This model recapitulates key pathological features of AD such as a progressive accumulation of parenchymal amyloid plaques and vascular amyloid deposits, altered glial responses and neurodegeneration. Leveraging multi-omics approaches, we found lipid accumulation and an exacerbated disease-associated transcriptomic response in methoxy-X04-positive, phagocytic microglia. Together, these findings highlight the potential of this novel, open-access mouse model to investigate AD pathogenesis and demonstrate that fibrillar Ab triggers lipid dysregulation and immuno-metabolic perturbations in phagocytic microglia.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

4 Bio Entities

Trail: Publication

0 Expression